(Q47691132)

4 February 2018

title

Outcome of patients with metastatic breast carcinoma treated at a private medical oncology clinic (English)

1 reference

4 February 2018

1 reference

1 reference

Anderson WF

1

1 reference

4 February 2018

Reeves JE

series ordinal

2

1 reference

4 February 2018

Elias A

series ordinal

3

1 reference

4 February 2018

Berkel H

series ordinal

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

4 February 2018

published in

Cancer

1 reference

4 February 2018

volume

88

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

95-107

1 reference

4 February 2018

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

A minimalist policy for breast cancer surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Why data bases should not replace randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Does chemotherapy improve survival in advanced breast cancer? A statistical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Survival of patients with metastatic breast cancer diagnosed between 1955 and 1980.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Annual hazard rates of recurrence for breast cancer after primary therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Treatment of relapse of breast cancer after adjuvant systemic therapy--review and guidelines for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Construction and validation of a practical prognostic index for patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

The lifetime risk of developing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

On the diagnosis and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Telling the truth about terminal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Recent trends in U.S. breast cancer incidence, survival, and mortality rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Metastatic breast cancer. Length and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Should we dream the impossible dream? The meaning of long-term survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

A comparison of randomized concurrent control groups with matched historical control groups: are historical controls valid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Simple procedures can markedly enhance automated immunoassay performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer. The French Epirubicin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Cancer of the breast: Its outcome as measured by the rate of dying and causes of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Putting the risk of breast cancer in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Kinetic concepts in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Are positive axillary nodes in breast cancer markers for incurable disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

"Cancer defeated": not if, but when--introducing the Biology of Neoplasia series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

Treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000101%2988%3A1%3C95%3A%3AAID-CNCR14%3E3.0.CO%3B2-P

10.1002/(SICI)1097-0142(20000101)88:1<95::AID-CNCR14>3.0.CO;2-P

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

release_v2qh423kpzajxldtwvjcbnl4oq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v2qh423kpzajxldtwvjcbnl4oq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 February 2018